Bionano Genomics, Inc. Overview
Pro stress-test →Bionano Genomics provides genome analysis solutions that enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research.
Strategic Profile
Pro stress-test →The company has shifted strategy towards focusing on its base of routine users of optical genome mapping (OGM) and VIA software as primary drivers of revenue and gross profit, with consistent utilization of OGM systems and software combined with year-over-year growth in consumables purchased by routine users. After significant reductions in costs and cash burn, together with gross margin improvements, the company has been able to extend cash runway while the global community of OGM users continues to publish groundbreaking research.
Competitive Landscape
Pro stress-test →Bionano competes with Azure Biosystems, Genomenon, Personal Genome Diagnostics, and WaferGen Bio-systems. The company differentiates through proprietary optical genome mapping technology focused on structural variation detection, complementing traditional sequencing approaches used by larger competitors in the broader genomics market.
Industry Context
Bionano Genomics, Inc. operates in Genomic Diagnostics & Life Sciences Instrumentation.
Key facts
Founded: 2003 · Headquarters: San Diego, California, United States · Revenue: $56M (2023)